REFERENCE
Earnshaw SR, Beard S, Lynch NO, Cooper A, Cowell W, Middelhoven H.A comparison of the cost-effectiveness of bisphosphonates using persistence data from a UK prospective RECT. Journal of Bone and Mineral Research 21 (Suppl. 1): 416-417, Sep 2006
Grima DT, Pasquale MK, Lange JL, Thompson M.Cost-effectiveness of risedronate versus ibandronate: impact of persistence. Journal of Bone and Mineral Research 21 (Suppl. 1): 181, Sep 2006
Rights and permissions
About this article
Cite this article
Once-monthly ibandronic acid cost effective. Pharmacoecon. Outcomes News 516, 6 (2006). https://doi.org/10.2165/00151234-200605160-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605160-00014